Literature DB >> 11757720

The beta-globin genotype E121Q/W15X (cd121GAA-->CAA/cd15TGG-->TGA) underlines Hb d/beta-(0) thalassaemia marked by domination of haemoglobin D.

M Ahmed1, M Stuhrmann, L Bashawri, W Kühnau, E H El-Harith.   

Abstract

Among 13,525 haemoglobin analyses performed in our laboratory we detected 21 cases of haemoglobin D (Hb D) disease. Investigation of a family affected with this abnormal haemoglobin revealed two cases of Hb D/beta-(0) thalassaemia for the first time among Saudi Arabs. The two patients were diagnosed as having chronic haemolytic anaemia of moderate severity on the basis of the haemoglobin level, haematocrit, mean corpuscular haemoglobin, mean corpuscular volume, reticulocyte count, red blood cell count microscopy, elevated serum conjugated and non-conjugated bilirubin, increased serum lactic dehydrogenase, and the occasional need for blood transfusions. Genetic analysis enabled the detection of compound heterozygosity for the missense E121Q (codon 121 GAA-->CAA) and stop W15X (codon 15 TGG-->TGA) mutations as causative of the clinical phenotype of Hb D-LosAngeles (Punjab)/beta-(0) thalassaemia. The disease manifested as domination of Hb D and moderate haemolytic anaemia. The co-inheritance of beta-(0) thalassaemia seems to be responsible for conferring the deleterious effect on the presentation of Hb D disease in these patients. The present result emphasizes the significance of molecular testing in resolving certain diagnostic ambiguities in haematology as in cases of heterozygous Hb D in association with beta-(0) thalassaemia which, by haemoglobin electrophoresis, may be misdiagnosed as Hb D homozygosity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757720     DOI: 10.1007/s002770100376

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  5 in total

1.  Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassaemia mutation for the screening of correctors of stop-codon mutations.

Authors:  Francesca Salvatori; Vera Cantale; Giulia Breveglieri; Cristina Zuccato; Alessia Finotti; Nicoletta Bianchi; Monica Borgatti; Giordana Feriotto; Federica Destro; Alessandro Canella; Laura Breda; Stefano Rivella; Roberto Gambari
Journal:  Biotechnol Appl Biochem       Date:  2009-07-09       Impact factor: 2.431

2.  Interaction of - α 3.7, ß Thalassemia Mutation IVS 1-5 and HbD Punjab in a Family: A Case Report.

Authors:  S Pandey; Ravi Ranjan; R M Mishra; Sw Pandey; R Saxena
Journal:  Indian J Clin Biochem       Date:  2012-03-24

3.  Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients.

Authors:  Francesca Salvatori; Giulia Breveglieri; Cristina Zuccato; Alessia Finotti; Nicoletta Bianchi; Monica Borgatti; Giordana Feriotto; Federica Destro; Alessandro Canella; Eleonora Brognara; Ilaria Lampronti; Laura Breda; Stefano Rivella; Roberto Gambari
Journal:  Am J Hematol       Date:  2009-11       Impact factor: 10.047

4.  New approaches for cholestasis in hemoglobinopathies.

Authors:  Pratibha Dhiman; Priyanka Saxena; Chhagan Bihari; Archana Rastogi; S K Sarin
Journal:  Blood Res       Date:  2015-06-25

Review 5.  A comprehensive review of the prevalence of beta globin gene variations and the co-inheritance of related gene variants in Saudi Arabians with beta-thalassemia.

Authors:  Mousa A Alaithan; Sayed AbdulAzeez; J Francis Borgio
Journal:  Saudi Med J       Date:  2018-04       Impact factor: 1.484

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.